Cdc7 kinase is a predictor of survival and a novel therapeutic target in epithelial ovarian carcinoma.

Kulkarni, Anjana A

Cdc7 kinase is a predictor of survival and a novel therapeutic target in epithelial ovarian carcinoma. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Apr 2009 - 2417-25 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1078-0432

10.1158/1078-0432.CCR-08-1276 doi


Apoptosis
Biomarkers, Tumor--analysis
Carcinoma--drug therapy
Cell Cycle
Cell Cycle Proteins--antagonists & inhibitors
Cell Line, Tumor
Cells, Cultured
Female
Genomic Instability
Humans
Ovarian Neoplasms--drug therapy
Ovary--enzymology
Protein Serine-Threonine Kinases--antagonists & inhibitors
RNA Interference
Survival Analysis